Michael Su

AG-120, an Oral, Selective, First-in-Class, Potent Inhibitor of Mutant IDH1, Reduces Intracellular 2HG and Induces Cellular Differentiation in TF-1 R132H Cells and Primary Human IDH1 Mutant AML Patient Samples Treated Ex Vivo

Hua Yang, K. Yen, O. Bernard, 2014 .

Carboxyl Terminus of hVIP/mov34 Is Critical for HIV-1-Vpr Interaction and Glucocorticoid-mediated Signaling*

M. Ramanathan, D. Weiner, Jerome A Chambers, 2002, The Journal of Biological Chemistry.

ML309: A potent inhibitor of R132H mutant IDH1 capable of reducing 2-hydroxyglutarate production in U87 MG glioblastoma cells

Mindy I. Davis, S. Gross, L. Dang, 2013 .

A fluorogenic screening platform enables directed evolution of an alkyne biosynthetic tool.

C. Bertozzi, Wenjun Zhang, Xuejun Zhu, 2016, Chemical communications.

Bacterial Genome Mining of Enzymatic Tools for Alkyne Biosynthesis.

Wenjun Zhang, Xuejun Zhu, K. Manickam, 2015, ACS chemical biology.

Probing the Acyl Carrier Protein-Enzyme Interactions within Terminal Alkyne Biosynthetic Machinery

Wenjun Zhang, Xuejun Zhu, Michael Su, 2018, bioRxiv.

Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation

K. Yen, V. Penard-Lacronique, B. Geoerger, 2023, Nature Medicine.

AG-221 Offers a Survival Advantage In a Primary Human IDH2 Mutant AML Xenograft Model

S. Choe, Hua Yang, K. Yen, 2013 .